Detalles de la búsqueda
1.
Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial.
Br J Cancer
; 124(8): 1373-1378, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33495601
2.
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Lancet
; 395(10218): 117-122, 2020 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839281
3.
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.
Breast Cancer Res Treat
; 186(1): 115-123, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33222093
4.
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies.
Breast Cancer Res Treat
; 188(1): 215-223, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33656637
5.
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Breast Cancer Res Treat
; 176(2): 377-386, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31041683
6.
Risk stratification in early breast cancer in premenopausal and postmenopausal women: integrating genomic assays with clinicopathological features.
Curr Opin Oncol
; 31(1): 29-34, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30299292
7.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
; 20(1): 103, 2018 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30180877
8.
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Lancet
; 387(10021): 866-73, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686313
9.
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.
Int J Cancer
; 139(9): 2127-34, 2016 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27381855
10.
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
Breast Cancer Res Treat
; 159(1): 71-8, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27447876
11.
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.
Breast Cancer Res Treat
; 158(3): 591-6, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27400912
12.
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Lancet Oncol
; 16(1): 67-75, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497694
13.
Markers for the identification of late breast cancer recurrence.
Breast Cancer Res
; 17: 10, 2015 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25848913
14.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Lancet
; 383(9922): 1041-8, 2014 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333009
15.
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.
Breast Cancer Res Treat
; 151(2): 309-18, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25917868
16.
Update on breast cancer risk prediction and prevention.
Curr Opin Obstet Gynecol
; 27(1): 92-7, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25517358
17.
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 15(13): 1460-1468, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25456365
18.
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Lancet
; 381(9880): 1827-34, 2013 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23639488
19.
Localisation microscopy with quantum dots using non-negative matrix factorisation.
Opt Express
; 22(20): 24594-605, 2014 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25322035
20.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Lancet Oncol
; 14(11): 1067-1076, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035531